Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Henry

Showing results (121-130 of 278) with videos related to

Pageof 28
Sort By:
Alimentary Pharmacology & Therapeutics|November 30, 2019
The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver diseaseJames M Paik, Rati Deshpande, Pegah Golabi, et al.
Journal of Viral Hepatitis|November 7, 2018
The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic diseaseZobair Younossi, Georgios Papatheodoridis, Patrice Cacoub, et al.
Hepatology (Baltimore, Md.)|September 25, 2018
Prevalence of Undetectable Vaccine-Induced Immunity Against Hepatitis B Virus in US Adults at High Risk for InfectionYee Hui Yeo, Michael H Le, Ellen T Chang, et al.
Journal of Hepatology|January 29, 2024
Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver diseaseZobair M Younossi, James M Paik, Maria Stepanova, et al.
Hepatology Communications|October 2, 2023
The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019James M Paik, Linda Henry, Youssef Younossi, et al.
Hepatology Communications|February 8, 2021
Direct-Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis CHaesuk Park, Hyun Jin Song, Xinyi Jiang, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 4, 2018
Confirmatory factor analysis of the Minnesota living with heart failure questionnaire among patients following open heart surgery for valve dysfunctionScott D Barnett, Eric L Sarin, Linda Henry, et al.
Digestive Diseases (Basel, Switzerland)|October 14, 2024
Disease Progression for Histologic Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Real-World: A Nationwide US StudyXinrong Zhang, Leslie Yeeman Kam, Scott D Barnett, et al.
Alimentary Pharmacology & Therapeutics|November 8, 2023
Treatment rates and factors associated with direct-acting antiviral therapy for insured patients with hepatitis C-related hepatocellular carcinoma - A real-world nationwide studyLeslie Y Kam, Yee Hui Yeo, Fanpu Ji, et al.
Digestive Diseases (Basel, Switzerland)|June 17, 2024
Impact of Income-to-Poverty Ratio on Long-Term Mortality of Persons with Chronic Liver Disease in the USA, 1999-2018Brian Thanh Nguyen, Vy Hoang Nguyen, Michael Le, et al.
Pageof 28

Showing results (121-130 of 278) with videos related to

Sort By:
Pageof 28
Alimentary Pharmacology & Therapeutics|November 30, 2019
The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver diseaseJames M Paik, Rati Deshpande, Pegah Golabi, et al.
Journal of Viral Hepatitis|November 7, 2018
The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic diseaseZobair Younossi, Georgios Papatheodoridis, Patrice Cacoub, et al.
Hepatology (Baltimore, Md.)|September 25, 2018
Prevalence of Undetectable Vaccine-Induced Immunity Against Hepatitis B Virus in US Adults at High Risk for InfectionYee Hui Yeo, Michael H Le, Ellen T Chang, et al.
Journal of Hepatology|January 29, 2024
Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver diseaseZobair M Younossi, James M Paik, Maria Stepanova, et al.
Hepatology Communications|October 2, 2023
The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019James M Paik, Linda Henry, Youssef Younossi, et al.
Hepatology Communications|February 8, 2021
Direct-Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis CHaesuk Park, Hyun Jin Song, Xinyi Jiang, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 4, 2018
Confirmatory factor analysis of the Minnesota living with heart failure questionnaire among patients following open heart surgery for valve dysfunctionScott D Barnett, Eric L Sarin, Linda Henry, et al.
Digestive Diseases (Basel, Switzerland)|October 14, 2024
Disease Progression for Histologic Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Real-World: A Nationwide US StudyXinrong Zhang, Leslie Yeeman Kam, Scott D Barnett, et al.
Alimentary Pharmacology & Therapeutics|November 8, 2023
Treatment rates and factors associated with direct-acting antiviral therapy for insured patients with hepatitis C-related hepatocellular carcinoma - A real-world nationwide studyLeslie Y Kam, Yee Hui Yeo, Fanpu Ji, et al.
Digestive Diseases (Basel, Switzerland)|June 17, 2024
Impact of Income-to-Poverty Ratio on Long-Term Mortality of Persons with Chronic Liver Disease in the USA, 1999-2018Brian Thanh Nguyen, Vy Hoang Nguyen, Michael Le, et al.
Pageof 28